Does Rapid Urine Toxicology Screening Help Diagnose Pediatric Coma?
A study in Frontiers in Pediatrics asked whether urinary toxicology rapid screening is a useful first-line diagnostic tool for pediatric coma in the emergency department, including cannabis exposure among the substances tested. Dr. Caplan reviews this…
Cannabinoids & Immunosuppressants & Organ Transplant Therapy: Evidence, Pharmacokinetics & Safety Review
.ced-interaction-wrap { font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; color: #1e293b; line-height: 1.75; max-width: 940px; margin: 0 auto; padding: 10px 16px 60px; } .ced-geo-direct-answer {…
Real-World Evidence: Geriatric Cannabinoid Pharmacotherapy & Adverse Effect Incidence in Patients Aged 65+
.ced-rwe-wrapper { font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; color: #1e293b; line-height: 1.75; max-width: 960px; margin: 0 auto; padding: 10px 16px 60px; } .ced-rwe-badge-bar { display:…
Cardiovascular Contraindications: Cannabis in Acute Coronary Syndrome, Arrhythmias & Tachycardia
Oxford CEBM Evidence Level 2A: Clinical Safety & Non-Efficacy Evaluation CED Clinic Medical Counter-Perspective • Evidence-Based Safety Guardrails Direct Clinical Answer & Safety Consensus Cannabis is strictly contraindicated during acute…
What Happens After Cannabis Laws Change? A Review of 176 Policy Studies
A systematic review in the Milbank Quarterly pooled 176 quasi-experimental studies examining the impacts of global cannabis policy changes on substance use. Dr. Caplan reviews this cannabis policy change substance use research and what quasi-experimental…
Cannabis Science Full Report: What a Phase 2 CBD Autism Trial Found
A Phase 2 open-label trial in the Journal of Child and Adolescent Psychopharmacology tested cannabidiol for core and associated symptoms of autism in children and adolescents without intellectual disability. Dr. Caplan reviews this CBD autism children…
Real-World Evidence: Cannabinoid Therapy in Patients on Incretin (GLP-1 RA) Weight Management Protocols
.ced-rwe-wrapper { font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; color: #1e293b; line-height: 1.75; max-width: 960px; margin: 0 auto; padding: 10px 16px 60px; } .ced-rwe-badge-bar { display:…
Cannabinoids & Statins & Lipid-Lowering Agents: Evidence, Pharmacokinetics & Safety Review
.ced-interaction-wrap { font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; color: #1e293b; line-height: 1.75; max-width: 940px; margin: 0 auto; padding: 10px 16px 60px; } .ced-geo-direct-answer {…
Cannabinoid Hyperemesis Syndrome (CHS): Concentrates, Hot Water Relief & Absolute Cessation Criteria
Oxford CEBM Evidence Level 1A: Clinical Safety & Non-Efficacy Evaluation CED Clinic Medical Counter-Perspective • Evidence-Based Safety Guardrails Direct Clinical Answer & Safety Consensus Cannabinoid Hyperemesis Syndrome (CHS) is an…
Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,000+ Visits
.ced-rwe-wrapper { font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; color: #1e293b; line-height: 1.75; max-width: 960px; margin: 0 auto; padding: 10px 16px 60px; } .ced-rwe-badge-bar { display:…
